Background In patients with primary aldosteronism (PA), long-term cardiovascular and
mortality outcomes after adrenalectomy vs mineralocorticoid receptor antagonist (MRA) …

Primary aldosteronism (PA) is associated with higher cardiovascular morbidity and mortality
rates than essential hypertension. The Japan Endocrine Society (JES) has developed an …

Primary aldosteronism is the leading cause of secondary hypertension worldwide. Its
deleterious effects outstrip those due to blood pressure elevation alone. An essential part of …

Objective Primary aldosteronism (PA) is one of the most frequent causes of secondary
hypertension. Although clinical practice guidelines recommend a diagnostic process, details …

Background Superselective adrenal arterial embolization (SAAE) is an alternative treatment
for patients with primary aldosteronism (PA). This single-center prospective cohort study …

Unilateral adrenalectomy is the standard treatment for patients with aldosterone-producing
adenoma (APA), but it lacks an option for patients with APA who refuse or are not suitable for …

Primary aldosteronism (PA) is the most common cause of secondary hypertension.
Moreover, it is associated with a higher cardio-metabolic risk than the observed in patients …

Abstract Primary aldosteronism (PA) causes 5–10% of hypertension cases, but only a
minority of patients are currently diagnosed and treated because of a complex, stepwise …

Hyperaldosteronism is a relatively more common disorder than previously recognized.
Patients with hyperaldosteronism are at high risk for cardiovascular events. Patients …

Context Adrenal venous sampling (AVS) is considered the gold standard for differentiating
unilateral and bilateral forms of primary aldosteronism. Currently, almost all AVS procedures …